CD38 (Hydrolase) Inhibitor Screening Kit (Fluorometric)
The Californer/10135182

Trending...
A plate-based fluorometric assay designed to screen, study and characterize potential inhibitors of CD38 hydrolase activity.

MILPITAS, Calif. - Californer -- Cluster of differentiation 38 (CD38), also known as cyclic ADP ribose hydrolase is a type II transmembrane glycoprotein that can function either as a receptor or as an enzyme. It is found on the surface of many immune cells, including plasma B cells, natural killer cells, CD4+, CD8+ etc. It is a multifunctional enzyme involved in cell-adhesion, calcium signaling and Nicotinamide Adenine Dinucleotide (NAD+) metabolism. The hydrolase activity of CD38 helps maintain the appropriate levels of NAD+ for all NAD+ dependent metabolic processes to occur. Elevated levels of CD38 are associated with aging, obesity, diabetes, heart disease, asthma, inflammation and tumorigenesis etc.

More on The Californer
BioVision's CD38 (Hydrolase) Inhibitor Screening Kit is a plate-based fluorometric assay designed to screen, study and characterize potential inhibitors of CD38 hydrolase activity. The assay utilizes a selective CD38 substrate to generate a fluorescent signal measured at Ex/Em = 300/410 nm. In the presence of potential CD38 hydrolase inhibitors, the fluorescent signal is reduced. The assay is quick, easy, and sensitive for high-throughput screening of CD38 inhibitors. Additionally, the kit includes a CD38 Inhibitor as a control inhibitor.

Figure: Inhibition of CD38 activity by Apigenin. IC50 was calculated to be 6.1 ± 0.1 μM. Assay was performed following the kit protocol.

For more information on this Assay Kit Cat# K2086, Visit: https://bit.ly/3ofloCb

Media Contact
Marketing BioVision
***@biovision.com
(408) 493-1800 EXt: 224


Source: BioVision, Inc.
Filed Under: Biotech

Show All News | Report Violation

0 Comments

Latest on The Californer